CVT-12012
本产品不向个人销售，仅用作科学研究，不用于任何人体实验及非科研性质的动物实验。
| CAS NO: | 1018675-35-8 |
| 规格: | ≥98% |
包装与价格：
| 包装 | 价格(元) |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 250mg | 电议 |
产品介绍
理化性质和储存条件
| Molecular Weight (MW) | 434.41 |
|---|
| Formula | C21H21F3N4O |
|---|
| CAS No. | 1018675-35-8 |
|---|
| Storage | -20℃ for 3 years in powder form |
|---|
| -80℃ for 2 years in solvent |
| Solubility (In vitro) | DMSO: 10 mM |
|---|
| Water: N/A |
| Ethanol: N/A |
| Chemical Name | 2-hydroxy-N-[2-[3-methyl-2-oxo-7-[[3-(trifluoromethyl)phenyl]methylamino]quinoxalin-1-yl]ethyl]acetamide |
|---|
| Synonyms | UNII-OH3J29Q653; CVT-12012; CVT 12012; CVT12012 |
|---|
实验参考方法
| In Vitro | CVT12012 (Compound 5b) displays the highest potency in both the microsomal and the HEPG2 SCD assays (IC50 38 nM and 6.1 nM, respectively) compared to the other methyl-substituted compounds[1]. |
|---|
| In Vivo | In a rat PK study, CVT-12012 demonstrates good oral bioavailability (78%). It appears that the oral absorption of CVT-12012 is not affected by a significant Pgp efflux, which is expected based on Caco-2 assay result. The plasma clearance of CVT-12012 is high (88 mL/min/kg) with elimination half-life of approximately 1 h[1]. |
|---|
m.cnreagent.com